December 1st, 2008 Posted in SENS | No Comments »

Since posting the video of Zheng Cui’s presentation from Aging 08, I have received emails asking why the website for the clinical trial has been taken down. As best I understand, the trial is currently on hold due to concerns surrounding FDA regulations. The private efforts by Kronos Laboratory in demonstrating the efficacy of granulocyte therapy in a human patient may presently be the cornerstone of research in this area.
A transcription of Dr. Cui’s presentation has been uploaded to Future Current. As the lecture relates, his research has demonstrated that there are certain strains of mice whose levels of a particular white blood cell variety, namely granulocytes, confer exceptional resistance to cancer. These mice can survive what would normally be lethal injections of cancer cells.
Whether granulocyte infusions can effect a similar result in humans has yet to be seen. One can hope for the best, and what’s more, there are various ways to volunteer time and attention to furthering this promising avenue of life extension research. If you live in Florida, there may be the chance for you to participate in donating granulocytes. Forms are available on the Kronos website, and there is the facebook group as well.